Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary

[1]  O. Mariani,et al.  The Genomic Landscape of Mucinous Breast Cancer. , 2019, Journal of the National Cancer Institute.

[2]  I. Petersen,et al.  SCLEROSING EPITHELIOID MESENCHYMAL NEOPLASM OF THE PANCREAS A PROPOSED NEW ENTITY , 2019, Modern Pathology.

[3]  B. Stecca,et al.  Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened , 2019, Front. Genet..

[4]  C. Hui,et al.  GLI2 Modulated by SUFU and SPOP Induces Intestinal Stem Cell Niche Signals in Development and Tumorigenesis. , 2019, Cell reports.

[5]  I. Ellis,et al.  Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors , 2018, Nature Communications.

[6]  I. Ellis,et al.  Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas , 2018, Nature Communications.

[7]  D. Levine,et al.  Small cell cancers of the female genital tract: Molecular and clinical aspects. , 2018, Gynecologic oncology.

[8]  A. Joyner,et al.  Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation , 2018, Proceedings of the National Academy of Sciences.

[9]  A. Rajkovic,et al.  Ovarian Follicular Theca Cell Recruitment, Differentiation, and Impact on Fertility: 2017 Update. , 2018, Endocrine reviews.

[10]  Ekta Khurana,et al.  MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB–NFIB fusion gene , 2018, The Journal of pathology.

[11]  Junwei Yang,et al.  FHL2 promotes tubular epithelial‐to‐mesenchymal transition through modulating β‐catenin signalling , 2017, Journal of cellular and molecular medicine.

[12]  Ming Tang,et al.  TumorFusions: an integrative resource for cancer-associated transcript fusions , 2017, Nucleic Acids Res..

[13]  Asha A. Nair,et al.  Gastroblastoma harbors a recurrent somatic MALAT1–GLI1 fusion gene , 2017, Modern Pathology.

[14]  B. Porse,et al.  EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas , 2017, Nature Medicine.

[15]  B. Taylor,et al.  Implementing Genome-Driven Oncology , 2017, Cell.

[16]  R. Segal,et al.  Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy. , 2016, Developmental cell.

[17]  A. Stromberg,et al.  NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data , 2016, Nucleic acids research.

[18]  C. Antonescu,et al.  Recurrent MALAT1–GLI1 oncogenic fusion and GLI1 up‐regulation define a subset of plexiform fibromyxoma , 2016, The Journal of pathology.

[19]  V. Seshan,et al.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing , 2016, Nucleic acids research.

[20]  R. Carpenter,et al.  Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors , 2016, Cancers.

[21]  J. Reis-Filho,et al.  Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing , 2016, Histopathology.

[22]  R. Wilson,et al.  INTEGRATE: gene fusion discovery using whole genome and transcriptome data , 2016, Genome research.

[23]  O. Mariani,et al.  Genomic landscape of adenoid cystic carcinoma of the breast , 2015, The Journal of pathology.

[24]  V. Reuter,et al.  A Survey of DICER1 Hotspot Mutations in Ovarian and Testicular Sex Cord-Stromal Tumors , 2015, Modern Pathology.

[25]  E. Oliva,et al.  Sclerosing Stromal Tumors With Prominent Luteinization During Pregnancy: A Report of 8 Cases Emphasizing Diagnostic Problems , 2015, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[26]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[27]  Jin Jiang,et al.  Multisite interaction with Sufu regulates Ci/Gli activity through distinct mechanisms in Hh signal transduction , 2015, Proceedings of the National Academy of Sciences.

[28]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[29]  L. Di Marcotullio,et al.  Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors , 2014, The EMBO journal.

[30]  Simion I. Chiosea,et al.  Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin , 2014, Genes, chromosomes & cancer.

[31]  Simion I. Chiosea,et al.  Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands , 2014, Nature Genetics.

[32]  R. Young,et al.  Ovarian tumors and tumor-like lesions in the first three decades. , 2014, Seminars in diagnostic pathology.

[33]  Mikhail Shugay,et al.  Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions , 2013, Bioinform..

[34]  Thomas Whitington,et al.  Transcription Factor Binding in Human Cells Occurs in Dense Clusters Formed around Cohesin Anchor Sites , 2013, Cell.

[35]  J. Rabban,et al.  A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord–stromal tumours , 2013, Histopathology.

[36]  A. Khanna,et al.  Sclerosing Stromal Tumor of Ovary: A Case Report , 2012, Case reports in pathology.

[37]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[38]  K. Mayo,et al.  The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells. , 2012, Molecular endocrinology.

[39]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[40]  Davis J. McCarthy,et al.  Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.

[41]  Steven J. M. Jones,et al.  Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. , 2012, The New England journal of medicine.

[42]  S. Angers,et al.  Gli proteins in development and disease. , 2011, Annual review of cell and developmental biology.

[43]  B. Weigelt,et al.  PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs , 2011, Oncogene.

[44]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[45]  Süleyman Cenk Sahinalp,et al.  deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..

[46]  D. Huntsman,et al.  FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the Ovary , 2011, The American journal of surgical pathology.

[47]  A. Børresen-Dale,et al.  Identification of fusion genes in breast cancer by paired-end RNA-sequencing , 2011, Genome Biology.

[48]  Ryan D. Morin,et al.  Mutation of FOXL2 in granulosa-cell tumors of the ovary. , 2009, The New England journal of medicine.

[49]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[50]  H. Horlings,et al.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck , 2009, Proceedings of the National Academy of Sciences.

[51]  Ben S. Wittner,et al.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.

[52]  E. Epstein.  Basal cell carcinomas: attack of the hedgehog , 2008, Nature Reviews Cancer.

[53]  Mark D. Robinson,et al.  Moderated statistical tests for assessing differences in tag abundance , 2007, Bioinform..

[54]  Maria Kasper,et al.  GLI transcription factors: mediators of oncogenic Hedgehog signalling. , 2006, European journal of cancer.

[55]  Yukari Kobayashi,et al.  Sclerosing stromal tumor of the ovary with elevated CA125 , 2005, The journal of obstetrics and gynaecology research.

[56]  M. Muenke,et al.  A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. , 2005, Human molecular genetics.

[57]  J. Grootegoed,et al.  Hedgehog signaling in mouse ovary: Indian hedgehog and desert hedgehog from granulosa cells induce target gene expression in developing theca cells. , 2005, Endocrinology.

[58]  J. Fletcher,et al.  Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). , 2004, The American journal of pathology.

[59]  R. Kurman,et al.  Calretinin, a More Sensitive but Less Specific Marker Than &agr;-Inhibin for Ovarian Sex Cord-Stromal Neoplasms: An Immunohistochemical Study of 215 Cases , 2002, The American journal of surgical pathology.

[60]  D. Wilhelm,et al.  The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation. , 2002, Biochimica et biophysica acta.

[61]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[62]  Joan G. Jones,et al.  Expression of Calretinin in Human Ovary, Testis, and Ovarian Sex Cord-Stromal Tumors , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[63]  M. Nakafuku,et al.  Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. , 1999, Development.

[64]  Q. Gu,et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.

[65]  C. James,et al.  Sporadic medulloblastomas contain PTCH mutations. , 1997, Cancer research.

[66]  R. Scully,et al.  Sclerosing stromal tumors of the ovary , 1973, Cancer.

[67]  N. Socci,et al.  Accelerating Discovery of Functional Mutant Alleles in Cancer. , 2018, Cancer discovery.

[68]  R. Young,et al.  Ovarian sex cord-stromal tumours and their mimics. , 2018, Pathology.

[69]  R. Kurman,et al.  WHO classification of tumours of female reproductive organs , 2014 .

[70]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[71]  J. Flanagan,et al.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.